Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.
Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.
Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.
The Hospital for Sick Children, Toronto, Ontario, Canada
University of Frankfurt, Medical Dept. II, Frankfurt, Germany
University Hospital, Medical Dept. II, Frankfurt, Germany
Ohio State University Medical Center, Columbus, Ohio, United States
Medizinische Klinik II, Johann Wolfgang Goethe Universität, Frankfurt/Main, Germany
University Hospital, Medical Dept. II, Frankfurt, Germany
Ohio State University, Columbus, Ohio, United States
St George Hospital, Kogarah, New South Wales, Australia
Princess Margaret Hospital, Toronto, Ontario, Canada
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.